Dr. Stephen J. Lemon, MD

Dr. Lemon practices at St. Michael Medical Center - Silverdale in Silverdale, Washington.

Dr. Lemon's NPI, 1386637288, was assigned on August 25, 2005. Dr. Lemon graduated from University Of Washington School Of Medicine in 1988. Dr. Lemon's Washington license number on file is MD00044664.

Dr. Lemon's primary practice is St. Michael Medical Center - Silverdale, at 1800 NW Myhre Rd, Silverdale, WA 98383 in Kitsap County. The practice phone is (564) 240-1000.

Dr. Lemon's primary practice is St. Michael Medical Center - Silverdale in Silverdale, Washington. Dr. Lemon is also affiliated with Fred Hutchinson Cancer Center. The medical group on file is Washington Permanente Medical Group, P.C. Dmand AI also links Dr. Lemon to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lemon practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Lemon's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lemon is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Lemon's licenses on file in 6 states: Washington, Arizona, Nebraska, Iowa, Maryland and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Lemon treats.

CMS data shows 153 Medicare services from Dr. Lemon across 3 procedure codes in 2024, for 117 Medicare patients. Medicare paid $10,125 for them. Every service was in an office.

CMS counts 117 Medicare patients who saw Dr. Lemon in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lemon's median patient age at 70, with 56% women.

In 2024, Dr. Lemon wrote 383 Medicare Part D claims for 98 patients. 83% of them were for generic drugs. CMS names the drug for 239 of them, across 6 drugs with 11 or more claims each, at $12,844 in total drug cost. In 2023, CMS named 715 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lemon for performance year 2024, reported through an alternative payment model (APM). Dr. Lemon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lemon as offering telehealth.

Dmand AI links 22 papers to Dr. Lemon, published from 2015 to 2016. The most frequent topics are Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasm Proteins and Ovarian Neoplasms. Dr. Lemon has published most often in Cancer. Dr. Lemon's most frequent co-authors are Elizabeth A. Coleman, MD, Patrick I. Borgen, MD and Kevin Wayne Hatton, MD.

Dmand AI links Dr. Lemon to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Adenomatous Polyps, Breast Neoplasms and Breast Neoplasms, Male.

CMS Open Payments shows 125 general payments to Dr. Lemon from 26 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Genentech, Inc. paid the most, $780.

Dmand AI lists 4 awards for Dr. Lemon, most recently Delta Omega Honor Society in Public Health, Alpha Chapter in 1992.

Dr. Lemon graduated from University Of Washington School Of Medicine in 1988. Dr. Lemon is a member of ACP.

Dr. Lemon is in network with 6 carriers, including Humana, Kaiser Permanente and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.